Carol Nunn
- Efficacy of fluticasone furoate (FF) as a monotherapy and in combination with vilanterol (VI) over 12 weeks in patients with persistent asthmaBy Eugene R. Bleecker, Jan Lötvall, Paul M. O'Bryne, Ashley Woodcock, William W. Busse, Richard Forth, Hilary Medley, Carol Nunn, Loretta Jacques and Eric D. BatemanEugene R. Bleecker1Center for Genomics and Personalized Medicine, Wake Forest School of Medicine, Winston-Salem, United StatesJan Lötvall2Krefting Research Centre, University of Gothenburg, SwedenPaul M. O'Bryne3Michael G DeGroote School of Medicine, McMaster University, Hamilton, United StatesAshley Woodcock4School of Translational Medicine, University of Manchester, United KingdomWilliam W. Busse5Department of Medicine, University of Wisconsin, Madison, United StatesRichard Forth6Quantitative Sciences Division, GlaxoSmithKline, Research Triangle Park, United StatesHilary Medley7Respiratory Medicines Development Centre, GlaxoSmithKline, Uxbridge, United KingdomCarol Nunn7Respiratory Medicines Development Centre, GlaxoSmithKline, Uxbridge, United KingdomLoretta Jacques7Respiratory Medicines Development Centre, GlaxoSmithKline, Uxbridge, United KingdomEric D. Bateman8Department of Medicine, University of Cape Town, South Africa
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.